The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 22, 2025 for Hima Bindu Potluri
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Hima Bindu Potluri disclosed that a Non-Disposal Undertaking (NDU) on 30,00,000 equity shares (3.38% of total share capital) was released on August 19, 2025, and a fresh pledge on the same number of shares was created on August 20, 2025 in favour of Vistra ITCL (India) Ltd (Debenture Trustee) on behalf of Avendus PE Investment Advisors. The net effect is neutral — the NDU has simply been replaced by a pledge with no change in the total number of encumbered shares. The pledged shares serve as security for Non-Convertible Debentures subscribed by Avendus PE, with funds to be utilised by Potluri Laboratories Pvt Ltd (a promoter group entity) for long-term strategic needs, working capital and general corporate purposes. Amount involved against the new pledge is Rs.165 crore. Total promoter encumbrance stands at 23.18% of promoter shareholding (the filing also flags 'Yes' on the 50%-of-promoter-holding threshold check).
No net change in encumbered shares, so direct dilution risk for minority shareholders is limited. However, a sizeable pledge (~Rs.165 cr) tied to debentures of a promoter group company (Potluri Labs) means investors should watch for any margin call or invocation risk if share prices or promoter financials weaken. The disclosure also signals continued reliance of the promoter group on promoter share-backed borrowing.